Production (Stage)
STAAR Surgical Company
STAA
$18.68
-$0.09-0.48%
NASDAQ
| 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | |
|---|---|---|---|---|---|
| Revenue | -14.44% | -2.64% | 10.01% | 8.83% | 10.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.44% | -2.64% | 10.01% | 8.83% | 10.70% |
| Cost of Revenue | 3.51% | 6.53% | 5.97% | 2.59% | 11.23% |
| Gross Profit | -19.35% | -5.17% | 11.15% | 10.60% | 10.55% |
| SG&A Expenses | 7.12% | 10.87% | 5.17% | 9.13% | 16.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.41% | 11.46% | 7.84% | 9.17% | 16.12% |
| Operating Income | -281.88% | -141.57% | 42.89% | 5.28% | -29.59% |
| Income Before Tax | -329.12% | -126.86% | 35.03% | -9.94% | -30.92% |
| Income Tax Expenses | -14.95% | -9.66% | 137.28% | 100.99% | 92.06% |
| Earnings from Continuing Operations | -564.64% | -194.66% | 6.99% | -35.61% | -53.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -564.64% | -194.66% | 6.99% | -35.61% | -53.32% |
| EBIT | -281.88% | -141.57% | 42.89% | 5.28% | -29.59% |
| EBITDA | -223.23% | -115.67% | 35.35% | 5.31% | -24.58% |
| EPS Basic | -557.42% | -193.33% | 5.42% | -36.47% | -53.83% |
| Normalized Basic EPS | -235.25% | -125.36% | 36.98% | -7.68% | -28.77% |
| EPS Diluted | -569.09% | -196.92% | 9.94% | -33.74% | -52.62% |
| Normalized Diluted EPS | -238.31% | -126.56% | 38.36% | -6.42% | -27.87% |
| Average Basic Shares Outstanding | 1.12% | 1.24% | 1.33% | 1.29% | 1.20% |
| Average Diluted Shares Outstanding | 0.57% | 0.04% | -0.04% | -0.32% | -0.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |